MedTrace Logo

Validation of NAD+ Measurements for Human Clinical Studies

NCT07416786 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-02-18

No results posted yet for this study

Summary

The purpose of this study is to determine nicotinamide adenine dinucleotide (NAD) levels in healthy adult subjects before and after supplementing with over-the counter nicotinamide riboside (NR) using magnetic resonance spectroscopy (MRS).

Conditions

  • Healthy Adults

Interventions

DIETARY_SUPPLEMENT

Oral NR Supplementation

Oral Nicotinamide Riboside (NR)

Sponsors & Collaborators

Principal Investigators

  • Ravinder Reddy, Ph.D. · University of Pennsylvania

  • Joseph A. Baur, Ph.D. · University of Pennsylvania

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2027-07-31
Completion
2028-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07416786 on ClinicalTrials.gov